Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding

Por Alexander T. Cohen, Megan Lewis, Augusta Connor, Stuart J. Connolly, Patrick Yue, John Curnutte, Raza Alikhan, Peter MacCallum, Joachim Tan, Laura Green
Publicado em 2022-04-01